Hachshara Hitachdashut: How Much of the Future Profit Really Remains After the Menora Deals

What Actually Remains For Shareholders

The main article argued that Menora is the bridge that lets Hachshara Hitachdashut push more projects into execution without stretching its own equity base even further. That is true. But a bridge like that is never free. The question for shareholders is not how many units moved into execution. The question is how much of the future profit on those units actually remains with the company after the waterfalls, the pre-existing partners, and the minority-interest layer that has already entered equity.

The quick-reading mistake is to treat the projected gross profit in the project tables as if it is already on its way to profit attributable to shareholders. In Menora 1, the report explicitly says the profitability that will actually remain with the company is expected to differ from the profitability presented in the project tables. In Menora 2, the tables have already been adjusted, at least approximately, to the estimated post-Menora split. That means the two deals cannot be read through the same lens.

There are three separate layers here. The first is project-level gross profit. The second is the portion that remains with the company after pre-existing partners and Menora. The third is what will eventually reach profit attributable to shareholders after corporate overhead, financing, tax, and in some cases non-controlling interests. If those layers are blurred together, project economics get read as listed-shareholder economics. That is the analytical mistake.

That chart matters precisely because the presentation is asymmetric. For Menora 1, it reflects a mechanical reading of the 2025 tables, not the final shareholder outcome. For Menora 2, it is already much closer to a shareholder reading because the report says the relevant projects were reflected in the tables according to an estimated split of roughly 60% to the company group and 40% to Menora. Each deal has to be unpacked separately.

Menora 1: The Tables Are Not The Shareholder Number

Menora 1 is structured so that the company group holds 65% of the limited-partner rights in the joint partnership and Menora holds 35%, while project equity is funded 40% by the company and 60% by Menora, up to an aggregate envelope of about ILS 166 million, around ILS 66 million from the company and around ILS 100 million from Menora. Above that sits a distribution waterfall that, on the working assumptions, reflects an estimated profit split of roughly 70% to the company and 30% to Menora. There is also a success-fee mechanism in favor of the company if project profitability, profit to cost, exceeds 15%.

That is the core point. The company is not asking the reader to look only at the legal ownership percentage. It is also not giving one final shareholder number. It writes explicitly that the profitability that will actually remain with the company is expected to differ from the profitability shown in the tables. In other words, the tables are an intermediate station, not the endpoint.

In the 2025 tables, the four Menora 1 projects carry aggregate projected gross profit of about ILS 317.2 million. A mechanical reading of the company share shown in the tables gets to about ILS 201.3 million. Even that number is not a shareholder number, but it does give the first-stage haircut.

What matters is the gap between three different numbers. ILS 317.2 million is project-level gross profit. About ILS 201.3 million is the portion implied by the effective company share in the tables. But the actual outcome still has to pass through the success-fee mechanism, through the agreed settlement logic between the parties, and in Hankin through a structure that leaves the company with only a 48.75% effective interest. Anyone reading Menora 1 as a simple 65% story is simplifying. Anyone reading it as a simple 70% story is simplifying in a different direction. The report itself says the real number is determined further down the waterfall.

There is also a clear project-level distinction. Based on the 2025 assumptions, Hankin shows projected gross profit of ILS 30.3 million against expected project cost of ILS 226.1 million, which translates into roughly 13.4% profit to cost. That sits below the 15% threshold that activates the success-fee mechanism. Bavli, Ramla Phase A, and Kiryat Yam Phases A+B sit above that threshold on the current assumptions. So Menora 1 is not one uniform economics package. It contains projects where the success-fee layer could improve the company's share and one project where that extra protection does not currently look relevant.

Put differently, Menora 1 does not simply “take 30%” and does not simply “leave 70%” in any mechanical way. It buys the company funding and execution speed, but in return it forces a much more precise project-by-project reading. This is exactly where project profit stops being one number and becomes a question of ordering inside the contractual waterfall.

Menora 2: 40% To Menora Does Not Mean 60% To The Company

Menora 2 looks cleaner, but this is exactly where the true haircut is easy to miss. In the presentation, the headline is ILS 200 million across six projects, with a note that Menora is entitled to roughly 40% of Hachshara Hitachdashut's share of each project's profit, alongside priority and protection mechanisms. In note 18(i), the framing is different: a total equity envelope of up to ILS 250 million, of which up to ILS 50 million comes from Hayishuv Hachadash and up to ILS 200 million comes from Menora. There is no contradiction here. ILS 200 million is Menora's money. ILS 250 million is the combined equity envelope.

The second, and much more important, point is that unlike Menora 1, the report says the relevant Menora 2 projects were already reflected in the tables according to an estimated split of roughly 60% to the company group and 40% to Menora. That is a major analytical statement, because it means the table numbers are no longer raw company-side development economics. They are already post-Menora numbers, at least on the working assumptions.

But even here the quick reading is still wrong. Sixty percent to the company group does not mean the listed company keeps 60% in every project. Some of these projects already had another partner before Menora entered, so the listed company is left with only about 30% or roughly one-third in practice.

That is the central analytical point of the second deal. “40% to Menora” sounds like a structure in which the company keeps 60% of profit. In practice, across the six projects, the portion left to the company in the 2025 tables is only about 43.5% of project-level projected gross profit. The reason is simple: Menora 2 sits on top of a pipeline that was not wholly owned by the company to begin with. In projects such as Borochov and Emek Refaim, where the pre-Menora company share is 50%, the deal reduces the listed-company economics to about 30%. In Herzl Bialik, where the base rights are lower, shareholders are left with roughly one-third.

So Menora 2 does more than finance the execution ramp. It also resets the correct unit of measurement. Anyone still thinking about project gross profit as “the company's profit” is reading the number at the plot level instead of at the shareholder level. In this deal, those are no longer the same thing.

The Minority Layer: The Capital Is Already In, The Attribution Has Not Fully Run Yet

The most important line for a shareholder test is note 14. The company says that after the cumulative investment conditions under Menora 1 were met, Menora transferred its equity share relating to Hankin and Ramla Phase A in a total amount of about ILS 53 million, and that portion was recorded in equity as non-controlling interests. In other words, the price of the funding bridge has already started to appear in the capital structure before most of the future profit has run through the income statement.

The 2025 financial statements make this very clear. Non-controlling interests rose to ILS 51.3 million by year-end, and the statement of changes in equity shows a transaction with non-controlling interests of ILS 53.0 million. At the same time, the loss attributable to non-controlling interests in 2025 was ILS 1.675 million. That is a good indication of where the company stands in the cycle: the partner's equity is already in, but the earnings sharing has not yet fully flowed through the P&L because the projects are still at an early execution stage.

That matters because it changes how the balance sheet should be read. It is easy to look at stronger equity and conclude that the funding issue is now solved. In practice, part of that equity already belongs to a partner sitting above ordinary shareholders. As Hankin, Ramla, and later other projects move into revenue recognition, that partner will not remain just an equity line. It will start cutting into the attribution line as well.

One more distinction matters here. As of December 31, 2025, the minority layer recorded in equity relates in practice only to Hankin and Ramla Phase A. By the March 2026 presentation, the company was already presenting Bavli as one of the three projects where conditions had been met and required capital had been injected. That means even within Menora 1, the move from theoretical funding to accounting minority is happening gradually, project by project, not in one step.

Bottom Line

The Menora deals do exactly what the company needs them to do. They convert part of the equity bottleneck into execution capacity. But they also make clear that Hachshara Hitachdashut's future profit is not one project number, and not even one company number. It is a profit stream that has to pass through partners, waterfalls, success fees, non-controlling interests, and above all the corporate funding and overhead layer of the listed company.

On a mechanical reading of the 2025 tables, the two Menora deals together leave the company with about ILS 400 million of projected gross profit out of roughly ILS 775 million at project level. Even that is not a shareholder line, and certainly not free cash. But it does show the economic cost of the funding bridge: far less than the raw development gross profit ultimately remains with the shareholders of the listed company.

The key lesson is not that the deals are bad. It is that they have to be read correctly. In Menora 1, the tables are still not the final shareholder number, so any rigid reading of 65% or 70% is an illusion. In Menora 2, the numbers are already closer to a shareholder reading, and that is exactly where it becomes clear that the combination of Menora and pre-existing partners leaves the company with less than half of projected gross profit in aggregate. For anyone trying to understand shareholder economics, that is not a technical footnote. It is the core of the story.